On September 10, IBM unveiled a hybrid quantum-classical AI framework that integrates quantum computing with neural networks, slashing training times for complex models by up to 40%. This invention, showcased at the Quantum World Congress, tackles problems like molecular modeling for drug discovery, previously infeasible with classical systems. By leveraging quantum entanglement, IBM’s system optimizes algorithms for pattern recognition, offering a glimpse into AI’s next frontier. This could revolutionize fields like pharmaceuticals, where simulating protein interactions once took weeks.

1 octobre 2025



